South Australian Current Regulations South Australian Current Regulations20—Regulation of prescription drugs—prescription of certain S8
poisons by medical practitioners (section 18(2) of Act)
(1) For the purposes
of section 18(2) of the Act—
(a) each
of the S8 poisons listed in column 1 of the table below, when used for the
purpose set out in column 2, is a prescribed prescription drug; and
(b) the
qualifications and requirements specified in that table alongside a drug in
column 3 are prescribed qualifications and requirements.
|
Prescription drug |
Use |
Qualifications and requirements | |
|---|---|---|---|
|
1 |
N,α-dimethyl-3,4-(methylenedioxy)phenylethylamine (MDMA) |
Human use, for the treatment of post-traumatic stress disorder |
A medical practitioner— (a) who
is registered in the specialty of psychiatry; and (b) for
whom an authority under section 19(5) of the Commonwealth Act that covers
MDMA is in force. |
|
2 |
Psilocybine (Psilocybin) |
Human use, for the treatment of treatment-resistant depression |
A medical practitioner— (a) who
is registered in the specialty of psychiatry; and (b) for
whom an authority under section 19(5) of the Commonwealth Act that covers
psilocybine is in force. |
(2) A medical
practitioner who prescribes an S8 poison listed in the table in
subregulation (1) must, within 1 business day of prescribing the poison
and for the purposes of the Chief Psychiatrist performing the Chief
Psychiatrist's functions under the Mental Health Act 2009 , give notice
to the Chief Psychiatrist—
(a) in a
form determined by the Chief Psychiatrist; and
(b)
containing such information as the Chief Psychiatrist may determine.